Retatrutide sIde effects like nausea, diarrhea, and constipation are more common at higher doses and tend to occur mainly during the dose-escalation period
PubMed laboratory research record [PMID: 39955114] PubMed record related to this compound for laboratory literature review
"Ipamorelin, a new growth hormone-releasing peptide, is a potent stimulator of growth hormone release in humans." The Journal of Clinical Endocrinology & Metabolism, 85(4), 12771280
In the sample with autoimmune hypothyroidism, the diagnosis had been made by endocrinologists at the Helsinki University Central Hospital, where the diagnostic criteria included elevated TPO antibodies, elevated TSH, reduced FT4, and ultrasound findings characteristic of autoimmune thyroiditis
many industry experts were skeptical that it would ever work
The companies listed in this report are a curated selection - not the full competitive universe